Product Images Anastrozole
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Anastrozole NDC 68071-3838 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pdp - 68071 3838 9
This is a description of a pharmaceutical product labeled as Anastrozole 1mg, manufactured by NuCare Pharmaceuticals, Inc. The product details include Lot number, NDC number, manufacturer's information, expiration date, GTIN, and instructions to contact a doctor for medical advice. It also includes a warning to keep the product out of reach of children and to store it at a controlled temperature of 68-77°F.*
Chemical Structure - anastrozole 01
Figure 1 - anastrozole 02
This data table shows the disease-free survival in months for patients in a study comparing anastrozole and tamoxifen treatments. The graph plots the proportion of patients alive and disease-free over a span of 90 months. The number of patients at risk for each treatment group is provided at various time points.*
Figure 2 - anastrozole 03
This is a data table showing the disease-free survival in months for patients receiving anastrozole and tamoxifen in a randomized treatment. The chart displays the proportion of patients alive and disease-free over time, with data points at 0, 6, 12, 18, 24, 30, 36, 42, 48, 54, 60, 66, 72, 78, 84, and 90 months. The number of patients at risk is also provided for each treatment group at different time points.*
Figure 3 - anastrozole 04
Figure 4 - anastrozole 05
Figure 5 - anastrozole 06
The provided text appears to be a table showing the time to progression in months for patients receiving randomized treatment with anastrozole and tamoxifen. The table allows for the comparison of progression rates between the two treatment groups over the specified time periods.*
Figure 6 - anastrozole 07
The text shows a graph displaying the progression of randomized treatment between Anastrozole and Tamoxifen over the course of 40 months. It indicates the number of subjects at risk for each month of the study. The chart visually represents how the proportion of subjects is not progressing uniformly over time.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
